SWK Holdings Provides Portfolio Update Highlighting Recent Achievements
Specialty Finance Portfolio Growth, Underlying Credit Performance Highlight Strong 2020
Closed Four Transactions During 2020, Deploying $35 Million
Two Milestone Payments Received from Cara Therapeutics Related to the Development of Oral KORSUVA™
Fourth Quarter and Full-Year 2020 Financial Results Expected in March 2021
News provided by
Share this article
Share this article
DALLAS, Feb. 16, 2021 /PRNewswire/ SWK Holdings Corporation (Nasdaq: SWKH), a life sciences focused specialty finance company catering to small and mid-sized commercial-stage companies, today provided an update on the progress and achievements of its portfolio and partner companies during the past year. SWK s strong performance is highlighted by 20% year-over-year growth in our earning assets to approximately $208 million accompanied by strong underlying credit trends, stated Winston Black, Chairman and CEO of SWK Holdings. Du
Share this article
Share this article
FORT COLLINS, Colo., Feb. 16, 2021 /PRNewswire/ Cytocom, Inc., a leading biopharmaceutical company creating first second-generation immune therapies, today provided an update regarding its CYTO-200 portfolio of clinical programs.
Cytocom has submitted an Investigational New Drug (IND) application with updated protocols to the U.S. Food and Drug Administration (FDA) to begin a Phase 2 clinical trial, to evaluate the safety and efficacy of CYTO-205 to slow or halt the progression of the SARS-CoV-2, the virus that causes COVID-19. Preclinical
in vitro studies using coronavirus strain 229E have demonstrated the potential of CYTO-205 to inhibit the replication of a coronavirus (strain 229E) in human lung cells. The trial, titled,
Share this article
Share this article
SEOUL, South Korea, Feb. 15, 2021 /PRNewswire/ A new study shows that the less-invasive saliva test for COVID-19 gives just as accurate results as those of the nasopharyngeal specimen.
A research team at the Department of Laboratory Medicine at Kangwon National University School of Medicine, led by Professor In-bum Suh, carried out the PCR test for COVID-19 on 90 hospitalized individuals with suspected COVID-19, both with saliva and nasopharyngeal methods. In order to collect sufficient specimen, samples were collected from study participants, who were required to refrain from any activities including eating, drinking, and smoking, for 30 minutes after they got up in the morning.
Share this article
Share this article
ATLANTA, Feb. 15, 2021 /PRNewswire/ Jan-Pro Cleaning & Disinfecting – One of the largest commercial cleaning franchise brands in the country – is continuing to provide cleaning and safety measures to help create a safe environment for tenants, employees, and customers across the United States. In 2020, JAN-PRO Cleaning & Disinfecting saw a five hundred percent increase in service requests and a record year in top line revenue as thousands of businesses across the country sought out essential cleaning services. The brand was recently awarded Entrepreneur Magazine s #1 commercial cleaning franchise, the 13
th year in a row. As the pandemic is expected to worsen over the next few months, JP Cleaning & Disinfecting small business owners are committed to providing everyone a safer community and continue to be the go-to trusted cleaning professionals.
/PRNewswire/ The U.S. Environmental Protection Agency (EPA) announced recently that certain copper alloys provide effective long-term protection against.